Brief: DSM Q1 Adjusted EBITDA Up At 487 Million Euros

Koninklijke DSM NV

03/05/2022 06:05

May 3 (Reuters) - Koninklijke DSM NV  DSMN.AS :
    * DSM PROVIDES Q1 2022 TRADING UPDATE
    * EXPECTS ITS HEALTH, NUTRITION & BIOSCIENCE ACTIVITIES TO
DELIVER
A HIGH-SINGLE DIGIT ADJUSTED EBITDA INCREASE
    * Q1 CONTINUING GROUP SALES EUR 2.59 BILLION VERSUS EUR 2.19
BILLION YEAR AGO
    * EXPECTS A MID-SINGLE DIGIT ADJUSTED EBITDA INCREASE, WITH
A
HIGH-SINGLE ADJUSTED NET OPERATING FREE CASH FLOW INCREASE
    * FULL YEAR OUTLOOK 2022 UNCHANGED
    * Q1 ADJUSTED EBITDA EUR 487 MILLION VERSUS EUR 441 MILLION
YEAR
AGO

Source text for Eikon:  ID:nPreggSGka 
Further company coverage:  DSMN.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))